These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3840523)

  • 1. Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase.
    Palfreyman MG; McDonald IA; Fozard JR; Mely Y; Sleight AJ; Zreika M; Wagner J; Bey P; Lewis PJ
    J Neurochem; 1985 Dec; 45(6):1850-60. PubMed ID: 3840523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
    Palfreyman MG; McDonald IA; Bey P; Schechter PJ; Sjoerdsma A
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):967-87. PubMed ID: 3266532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of monoamine oxidase within monoaminergic neurons in the rat brain by (E)-beta-fluoromethylene-m-tyrosine (MDL 72394).
    Fagervall I; Ross SB
    J Neurochem; 1989 Feb; 52(2):467-71. PubMed ID: 2521360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase.
    Palfreyman MG; Mir AK; Kubina M; Middlemiss DN; Richards M; Tricklebank MD; Fozard JR
    Eur J Pharmacol; 1986 Oct; 130(1-2):73-89. PubMed ID: 3780861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute effect of the bioprecursor of the selective brain MAO-A inhibitor, MDL 72392, on rat pineal melatonin biosynthesis.
    Oxenkrug GF; Requintina PJ; Yuwiler A; Palfreyman MG
    J Neural Transm Suppl; 1994; 41():377-9. PubMed ID: 7931254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat.
    Treseder SA; Rose S; Summo L; Jenner P
    J Neural Transm (Vienna); 2003 Mar; 110(3):229-38. PubMed ID: 12658372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of stereo (R and S) and geometric (E and Z) isomers of [18F]fluoro-beta-fluoromethylene-m-tyrosine derivatives: in vivo probes of central dopaminergic function.
    Lacan G; Satyamurthy N; Barrio JR
    Nucl Med Biol; 1999 May; 26(4):359-63. PubMed ID: 10382837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I; Ross SB
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific irreversible monoamine oxidase B inhibitors stimulate gene expression of aromatic L-amino acid decarboxylase in PC12 cells.
    Li XM; Juorio AV; Paterson IA; Zhu MY; Boulton AA
    J Neurochem; 1992 Dec; 59(6):2324-7. PubMed ID: 1431909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The O-methylated derivative of L-DOPA, 3-O-methyl-L-DOPA, fails to inhibit neuronal and non-neuronal aromatic L-amino acid decarboxylase.
    Soares-da-Silva P; Parada A; Serrão P
    Brain Res; 2000 Apr; 863(1-2):293-7. PubMed ID: 10773222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition by 4,alpha-dimethyl-m-tyramine (H77/77) and 4-methyl-alpha-ethyl-m-tyramine (H75/12) of the monoamine oxidase within serotonergic and noradrenergic neurons in the rat brain.
    Fagervall I; Kelder D; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):143-7. PubMed ID: 2460774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a gas chromatographic/mass spectrometric method for the determination of (E)-beta-fluoromethylene-m-tyrosine and its active metabolite in human plasma and urine.
    Schoun J; Duléry B; Haegele KD
    Biol Mass Spectrom; 1992 Dec; 21(12):625-32. PubMed ID: 1477108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase after inhibiting monoamine oxidase-A.
    Cho S; Duchemin AM; Neff NH; Hadjiconstantinou M
    Eur J Pharmacol; 1996 Oct; 314(1-2):51-9. PubMed ID: 8957218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
    Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.
    Demarest KT; Smith DJ; Azzaro AJ
    J Pharmacol Exp Ther; 1980 Nov; 215(2):461-8. PubMed ID: 7441510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [18F]Fluoro-beta-fluoromethylene-m-tyrosine derivatives show stereo, geometrical, and regio specificities as in vivo central dopaminergic probes in monkeys.
    Huang SC; Quintana J; Satyamurthy N; Lacan G; Yu DC; Phelps ME; Barrio JR
    Nucl Med Biol; 1999 May; 26(4):365-70. PubMed ID: 10382838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
    Da Prada M; Kettler R; Keller HH; Burkard WP; Muggli-Maniglio D; Haefely WE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):400-14. PubMed ID: 2783611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic MAO A and MAO B inhibition decreases the 5-HT1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase.
    Sleight AJ; Marsden CA; Palfreyman MG; Mir AK; Lovenberg W
    Eur J Pharmacol; 1988 Sep; 154(3):255-61. PubMed ID: 3234480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.